NeoGenomics Inc (NEO) stock news · rev $727.3M
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
This NEO news page leads with what NeoGenomics Inc filed — not a scraped headline mill.
No cached 8-K sentence for NEO yet. We will not pad this page with generic market recap.
Latest reported NEO revenue for 2025-12-31 was $727.3M. Net income was -$108.0M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. NEO currently screens at market cap $924.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NEO stock page; for the tape open the quote page.
NEO stock news FAQ
What are NEO's latest revenue and net income?
Latest cached NeoGenomics Inc (NEO) revenue for Dec 31, 2025 was $727.3M. Net income was -$108.0M. Statements: https://lician.com/financials/neo
How did NEO revenue change from the prior cached period?
Cached NeoGenomics Inc (NEO) revenue was up 10.1% from $660.6M (Dec 31, 2024) to $727.3M (Dec 31, 2025). Statements: https://lician.com/financials/neo
What is NEO's market cap?
NeoGenomics Inc (NEO) market cap is $924.0M on the latest cached fundamentals snapshot.
What kind of company is NEO?
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Where is NEO stock news listed?
Cached stock news for NeoGenomics Inc (NEO) is listed at https://lician.com/news/neo. Filings: https://lician.com/sec/neo
Not investment advice.